Works matching IS 0195668X AND DT 2005 AND VI 26

Results: 556
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Who wants to be normal?

    Published in:
    European Heart Journal, 2005, v. 26, n. 24, p. 2605, doi. 10.1093/eurheartj/ehi596
    By:
    • Lindeberg, Staffan
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.

    Published in:
    European Heart Journal, 2005, v. 26, n. 24, p. 2706, doi. 10.1093/eurheartj/ehi499
    By:
    • Lenzen, Mattie J.;
    • Boersma, Eric;
    • Scholte op Reimer, Wilma J.M.;
    • Balk, Aggie H.M.M.;
    • Komajda, Michel;
    • Swedberg, Karl;
    • Follath, Ferenc;
    • Jimenez-Navarro, Manuel;
    • Simoons, Maarten L.;
    • Cleland, John G.F.
    Publication type:
    Article
    23

    Impaired left ventricular function in obesity?

    Published in:
    European Heart Journal, 2005, v. 26, n. 24, p. 2742, doi. 10.1093/eurheartj/ehi572
    By:
    • Barker, Diane;
    • Williams, Simon G.;
    • McLoughlin, Hilary;
    • Tan, Lip-Bun
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Recommendations for the management of patients after heart valve surgery.

    Published in:
    European Heart Journal, 2005, v. 26, n. 22, p. 2463, doi. 10.1093/eurheartj/ehi426
    By:
    • Butchart, Eric G.;
    • Gohlke-Bärwolf, Christa;
    • Antunes, Manuel J.;
    • Tornos, Pilar;
    • De Caterina, Raffaele;
    • Cormier, Bertrand;
    • Prendergast, Bernard;
    • Iung, Bernard;
    • Bjornstad, Hans;
    • Leport, Catherine;
    • Hall, Roger J.C.;
    • Vahanian, Alec
    Publication type:
    Article
    30

    Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.

    Published in:
    European Heart Journal, 2005, v. 26, n. 23, p. 2524, doi. 10.1093/eurheartj/ehi459
    By:
    • Mukherjee, Debabrata;
    • Topol, Eric J.;
    • Bertrand, Michel E.;
    • Kristensen, Steen D.;
    • Herrmann, Howard C.;
    • Neumann, Franz-Josef;
    • Yakubov, Steven J.;
    • Bassand, Jean-Pierre;
    • McClure, Rick R.;
    • Stone, Gregg W.;
    • Ardissino, Diego;
    • Moliterno, David J.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.

    Published in:
    European Heart Journal, 2005, v. 26, n. 24, p. 2689, doi. 10.1093/eurheartj/ehi473
    By:
    • Jost, Andreas;
    • Rauch, Bernhard;
    • Hochadel, Matthias;
    • Winkler, Ralph;
    • Schneider, Steffen;
    • Jacobs, Martina;
    • Kilkowski, Caroline;
    • Kilkowski, Andreas;
    • Lorenz, Herbert;
    • Muth, Kerstin;
    • Zugck, Christian;
    • Remppis, Andrew;
    • Haass, Markus;
    • Senges, Jochen
    Publication type:
    Article
    38
    39
    40
    41
    42

    Coronary collaterals.

    Published in:
    European Heart Journal, 2005, v. 26, n. 23, p. 2595, doi. 10.1093/eurheartj/ehi515
    By:
    • Dewey, Marc;
    • Dübel, Hans-Peter
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50